BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 35301675)

  • 1. Prognostic significance of laterality in lung neuroendocrine tumors.
    La Salvia A; Persano I; Siciliani A; Verrico M; Bassi M; Modica R; Audisio A; Zanata I; Trabalza Marinucci B; Trevisi E; Puliani G; Rinzivillo M; Parlagreco E; Baldelli R; Feola T; Sesti F; Razzore P; Mazzilli R; Mancini M; Panzuto F; Volante M; Giannetta E; Romero C; Appetecchia M; Isidori A; Venuta F; Ambrosio MR; Zatelli MC; Ibrahim M; Colao A; Brizzi MP; García-Carbonero R; Faggiano A
    Endocrine; 2022 Jun; 76(3):733-746. PubMed ID: 35301675
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular markers help characterize neuroendocrine lung tumors.
    Rusch VW; Klimstra DS; Venkatraman ES
    Ann Thorac Surg; 1996 Sep; 62(3):798-809; discussion 809-10. PubMed ID: 8784011
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Two cases of lung neuroendocrine carcinoma with carcinoid morphology.
    Inafuku K; Yokose T; Ito H; Eriguchi D; Samejima J; Nagashima T; Nakayama H; Suzuki M; Yamada K; Masuda M
    Diagn Pathol; 2019 Sep; 14(1):104. PubMed ID: 31511024
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Survival analysis of 200 pulmonary neuroendocrine tumors with clarification of criteria for atypical carcinoid and its separation from typical carcinoid.
    Travis WD; Rush W; Flieder DB; Falk R; Fleming MV; Gal AA; Koss MN
    Am J Surg Pathol; 1998 Aug; 22(8):934-44. PubMed ID: 9706973
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Angioside: The role of Angiogenesis and Hypoxia in Lung Neuroendocrine Tumours According to Primary Tumour Location in Left or Right Parenchyma.
    La Salvia A; Carletti R; Verrico M; Feola T; Puliani G; Bassi M; Sesti F; Pernazza A; Mazzilli R; Lamberti G; Siciliani A; Mancini M; Manai C; Venuta F; Ibrahim M; Tomao S; D'Amati G; Di Gioia C; Giannetta E; Cappuzzo F; Faggiano A
    J Clin Med; 2022 Oct; 11(19):. PubMed ID: 36233825
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Automated quantification of Ki-67 proliferative index of excised neuroendocrine tumors of the lung.
    Liu SZ; Staats PN; Goicochea L; Alexiev BA; Shah N; Dixon R; Burke AP
    Diagn Pathol; 2014 Oct; 9():174. PubMed ID: 25318848
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diffuse idiopathic pulmonary neuroendocrine cell hyperplasia (DIPNECH): Prevalence, clinicopathological characteristics and survival outcome in a cohort of 311 patients with well-differentiated lung neuroendocrine tumours.
    Hayes AR; Luong TV; Banks J; Shah H; Watkins J; Lim E; Patel A; Grossman AB; Navalkissoor S; Krell D; Caplin ME
    J Neuroendocrinol; 2022 Oct; 34(10):e13184. PubMed ID: 36121922
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Advances in the Diagnosis and Management of Well-Differentiated and Intermediate-Differentiated Neuroendocrine Tumors of the Lung.
    Wolin EM
    Chest; 2017 May; 151(5):1141-1146. PubMed ID: 27373769
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Analysis on the characteristics and prognosis of pulmonary neuroendocrine tumors.
    Wu BS; Hu Y; Sun J; Wang JL; Wang P; Dong WW; Tao HT; Gao WJ
    Asian Pac J Cancer Prev; 2014; 15(5):2205-10. PubMed ID: 24716958
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Thyroid transcription factor-1 expression in lung neuroendocrine tumours: a gender-related biomarker?
    La Salvia A; Siciliani A; Rinzivillo M; Verrico M; Baldelli R; Puliani G; Modica R; Zanata I; Persano I; Fanciulli G; Bassi M; Mancini M; Bellino S; Giannetta E; Ibrahim M; Panzuto F; Brizzi MP; Faggiano A
    Endocrine; 2024 Feb; 83(2):519-526. PubMed ID: 37775725
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pulmonary neuroendocrine tumors: study of 266 cases focusing on clinicopathological characteristics, immunophenotype, and prognosis.
    Zhang S; Chen J; Zhang R; Xu L; Wang Y; Yuan Z; Hou X; Feng J
    J Cancer Res Clin Oncol; 2023 Mar; 149(3):1063-1077. PubMed ID: 35249158
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neuroendocrine tumors of the lung: A five-year retrospective experience of Egyptian NCI (2010-2014).
    Saber M; Ismail Y; Alieldin N; Loay I; El Zawahry M
    J Egypt Natl Canc Inst; 2018 Dec; 30(4):151-158. PubMed ID: 30470605
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Neuroendocrine neoplasms of the mediastinum].
    Brcic L; Heidinger M; Popper H
    Pathologe; 2016 Sep; 37(5):434-40. PubMed ID: 27507161
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic factors in neuroendocrine lung tumors: a Spanish Multicenter Study. Spanish Multicenter Study of Neuroendocrine Tumors of the Lung of the Spanish Society of Pneumonology and Thoracic Surgery (EMETNE-SEPAR).
    García-Yuste M; Matilla JM; Alvarez-Gago T; Duque JL; Heras F; Cerezal LJ; Ramos G
    Ann Thorac Surg; 2000 Jul; 70(1):258-63. PubMed ID: 10921719
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pulmonary neuroendocrine carcinomas. A review of 234 cases and a statistical analysis of 50 cases treated at one institution using a simple clinicopathologic classification.
    Huang Q; Muzitansky A; Mark EJ
    Arch Pathol Lab Med; 2002 May; 126(5):545-53. PubMed ID: 11958659
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Pulmonary carcinoid: analysis of a single institutional experience and prognostic factors].
    Correia Sda S; Pinto C; Bernardo J
    Acta Med Port; 2014; 27(6):749-54. PubMed ID: 25641291
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Histologic features of low- and intermediate-grade neuroendocrine carcinoma (typical and atypical carcinoid tumors) of the lung.
    Tsuta K; Raso MG; Kalhor N; Liu DD; Wistuba II; Moran CA
    Lung Cancer; 2011 Jan; 71(1):34-41. PubMed ID: 20462655
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pulmonary neuroendocrine tumors: study of 90 cases focusing on clinicopathological characteristics, immunophenotype, preoperative biopsy, and frozen section diagnoses.
    Yeh YC; Chou TY
    J Surg Oncol; 2014 Mar; 109(3):280-6. PubMed ID: 24301337
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunohistochemical analysis of OTP and NKX6.1 in neuroendocrine tumors of the lung and pancreas.
    Yoxtheimer LM; Heymann JJ; Cohen C; Rao RA; Goyal A; Siddiqui MT
    Diagn Cytopathol; 2018 Dec; 46(12):1010-1014. PubMed ID: 30284410
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognosis of Patients with Bronchopulmonary Neuroendocrine Neoplasms in a Tertiary Neuroendocrine Tumor Centre of Excellence.
    Rewitz KS; Grønbæk H; Tabaksblat EM; Dahl Baunwall SM; Dam G
    Neuroendocrinology; 2022; 112(12):1214-1224. PubMed ID: 35671706
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.